encyclopedia of medical concepts
ψ 
ψ 
ψ 

Neuroleptic Malignant Syndrome

More information in Books or onNLM PubMed
Definition: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)  caused by tranquilizing agents so do not use /chem ind    Other names Neuroleptic-Malignant Syndrome, Neuroleptic Induce; Neuroleptic-Induced Neuroleptic Malignant Syndrome; Syndromes, Neuroleptic Malignant; Syndrome, Neuroleptic Malignant; Neuroleptic Malignant Syndromes; Neuroleptic Malignant Syndrome, Neuroleptic Induce; Neuroleptic Induced Neuroleptic Malignant Syndrome; NMSs (Neuroleptic Malignant Syndrome); NMS (Neuroleptic Malignant Syndrome)

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy